536 results on '"Hepatitis C infection"'
Search Results
2. Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)
3. Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam (MOVIDA-Hep2)
4. DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
5. Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis.
6. Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders
7. Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders.
8. Pembrolizumab With or Without Elbasvir/Grazoprevir and Ribavirin in Treating Patients With Advanced Refractory Liver Cancer
9. Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease.
10. Efficacy and Safety of Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir Tablets for the Treatment of Chronic HCV Infection: A Prospective, Multi-center Real-world Study.
11. Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
12. Hepatitis C virus infection in children and adolescents: a management update
13. Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysisResearch in context
14. Migrants and hepatitis: A tale of two worlds.
15. Measuring Hazards of Undetectable Viral Load among Hepatitis C Antibody Positive Residents of a Large Southern California County.
16. Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects
17. A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
18. Unexpected high frequency of anti-thyroid peroxidase (anti-TPO) antibodies in Golestan province, Iran
19. Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam (CoViet-C)
20. A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults (GARNET)
21. Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt
22. Unexpected high frequency of anti-thyroid peroxidase (anti-TPO) antibodies in Golestan province, Iran.
23. Successful treatment of infectious endocarditis-associated glomerulonephritis during active hepatitis C infection: a case report
24. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)
25. Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)
26. Prevalence of HCV Genotypes in Correlation with Viral Load in Northern Region of Iraq.
27. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection.
28. Interaction Between Paroxetine and Telaprevir (ROLEX)
29. Effects of Persistent Innate Immune Activation on Vaccine Efficacy
30. Successful treatment of infectious endocarditis-associated glomerulonephritis during active hepatitis C infection: a case report.
31. Distinct Expression Patterns of Genes Coding for Biological Response Modifiers Involved in Inflammatory Responses and Development of Fibrosis in Chronic Hepatitis C: Upregulation of SMAD-6 and MMP-8 and Downregulation of CAV-1, CTGF, CEBPB, PLG, TIMP-3, MMP-1, ITGA-1, ITGA-2 and LOX
32. MACHINE LEARNING-BASED CLASSIFICATION OF HBV AND HCV-RELATED HEPATOCELLULAR CARCINOMA USING GENOMIC BIOMARKERS.
33. Epidemiological correlates of hepatitis C infection- A case control analysis from a tertiary care hospital
34. A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions
35. Emerging Management of Hepatitis C in Transplant
36. Hepatocellular Carcinoma in Pakistan: An Update
37. Prevalence and Risk Factors of Hepatitis C Virus Infection Among High-risk Egyptian Children
38. Treatment of pediatric patients with Down syndrome, acute lymphoblastic leukemia, and hepatitis C infection by direct-acting antivirals
39. Case Report of Hepatitis C Treatment Success in Male With Decompensated Cirrhosis and Polysubstance Abuse: The Important Role of the Pharmacist in Active Care Coordination.
40. Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic.
41. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study.
42. A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection
43. HCV-HIV Co-infected Patient Cohort in Thailand
44. Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
45. Hepatitis C Infection in World Trade Center Responders
46. Hepatitis C virus infection in children and adolescents: a management update
47. Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)
48. A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals
49. A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
50. The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.